Identification and validation of key extracellular proteins as the potential biomarkers in diabetic nephropathy

被引:1
|
作者
Pan, Wei [1 ]
Zhang, Qiankun [2 ]
Gong, Xiaohua [1 ]
Wu, Wenjun [1 ]
Zhou, Qi [1 ]
机构
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Wenzhou 325015, Peoples R China
[2] Zhejiang Univ, Wenzhou Med Univ, Lishui Cent Hosp, Dept Nephrol,Affiliated Hosp 5,Lishui Hosp, Lishui 323000, Peoples R China
关键词
TNF; Extracellular matrix; Dendritic cell; Diabetic nephropathy; Glycosaminoglycan degradation; KIDNEY-DISEASE; HIGH GLUCOSE; EXPRESSION; MODEL; CELL; TNF;
D O I
10.1186/s40001-024-02120-y
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective Accumulation of extracellular matrix (ECM) proteins in the glomerular mesangial region is a typical hallmark of diabetic nephropathy (DN). However, the molecular mechanism underlying ECM accumulation in the mesangium of DN patients remains unclear. The present study aims to establish a connection between extracellular proteins and DN with the goal of identifying potential biomarkers for this condition. Methods Differentially expressed genes (DEGs) between DN kidney tissue and healthy kidney tissue were analyzed using the public data GSE166239. Two gene lists encoding extracellular proteins were then utilized to identify extracellular protein-differentially expressed genes (EP-DEGs). Functional enrichment analyses, including Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses, were performed on these EP-DEGs. A protein-protein interaction (PPI) network was established to identify key EP-DEGs. Furthermore, the diagnostic ability, immune cell infiltration, and clinical relevance of these EP-DEGs were investigated. Immunohistochemistry (IHC) staining of paraffin-embedded renal tissues was performed to validate the accuracy of the bioinformatic results. Results A total of 1204 DEGs were identified, from which 162 EP-DEGs were further characterized by overlapping with extracellular protein gene lists. From the PPI network analysis, five EP-DEGs (e.g., TNF, COL1A1, FN1, MMP9, and TGFB1) were identified as candidate biomarkers. TNF, COL1A1, and MMP9 had a high diagnostic accuracy for DN. Assessment of immune cell infiltration revealed that the expression of TNF was positively associated with resting dendritic cells (DCs) (r = 0.85, P < 0.001) and M1 macrophages (r = 0.62, P < 0.05), whereas negatively associated with regulatory T cells (r = - 0.62, P < 0.05). Nephroseq v5 analysis demonstrated a negative correlation between the estimated glomerular filtration rate (eGFR) and TNF expression (r = - 0.730, P = 0.025). Gene set enrichment analysis (GSEA) revealed significant enrichment of glycosaminoglycan (GAG) degradation in the high-TNF subgroup. IHC staining of renal tissues confirmed significantly elevated TNF-a expression and decreased hyaluronic acid (HA) levels in the DN group compared to controls (both P < 0.05), with a negative correlation observed between TNF-a and HA (r = - 0.691, P = 0.026). Conclusion Our findings suggest that TNF may play a pivotal role in the progress of DN by driving ECM accumulation, and this process might involve GAG degradation pathway activation.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Identification and Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Relapsing-Remitting Multiple Sclerosis
    Li, Meng
    Chen, Hongping
    Yin, Pengqi
    Song, Jihe
    Jiang, Fangchao
    Tang, Zhanbin
    Fan, Xuehui
    Xu, Chen
    Wang, Yingju
    Xue, Yang
    Han, Baichao
    Wang, Haining
    Li, Guozhong
    Zhong, Di
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [2] Systematic identification of key extracellular proteins as the potential biomarkers in lupus nephritis
    Zhou, Xue
    Zhang, Yuefeng
    Wang, Ning
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [3] Identification and Preliminary Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Hashimoto's Thyroiditis by Comprehensive Analysis
    Xi, Zihan
    Yang, Tinglin
    Huang, Tao
    Zhou, Jun
    Yang, Peng
    Cappellano, Giuseppe
    Czarnecka-Chrebelska, Karolina H.
    BIOMEDICINES, 2023, 11 (12)
  • [4] Identification of key biomarkers in diabetic nephropathy via bioinformatic analysis
    Zeng, Mengru
    Liu, Jialu
    Yang, Wenxia
    Zhang, Shumin
    Liu, Fuyou
    Dong, Zheng
    Peng, Youming
    Sun, Lin
    Xiao, Li
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (05) : 8676 - 8688
  • [5] Identification and experimental validation of key extracellular proteins as potential targets in intervertebral disc degeneration
    Zhang, G-Z
    Li, L.
    Luo, Z-B.
    Zhang, C-Y.
    Wang, Y-G
    Kang, X-W
    BONE & JOINT RESEARCH, 2023, 12 (09): : 522 - 535
  • [6] Identification and validation of key biomarkers for the early diagnosis of diabetic kidney disease
    Yu, Wei
    Wang, Ting
    Wu, Feng
    Zhang, Yiding
    Shang, Jin
    Zhao, Zhanzheng
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] Identification of copper-related biomarkers and potential molecule mechanism in diabetic nephropathy
    Ming, Jie
    Sana, Si Ri Gu Leng
    Deng, Xijin
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [8] IDENTIFICATION OF URINARY MICRORNA BIOMARKERS FOR DIABETIC NEPHROPATHY
    Beltrami, Cristina
    Simpson, Kate A.
    Jesky, Mark D.
    Jenkins, Robert H.
    Phillips, Aled O.
    Satchell, Simon C.
    Cockwell, Paul
    Fraser, Donald J.
    Bowen, Timothy
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [9] Proteomic identification of urinary biomarkers of diabetic nephropathy
    Rao, Paturi V.
    Lu, Xinfang
    Standley, Melissa
    Pattee, Patrick
    Neelima, Gundupalle
    Girisesh, Gudige
    Dakshinamurthy, K. V.
    Roberts, Charles T., Jr.
    Nagalla, Srinivasa R.
    DIABETES CARE, 2007, 30 (03) : 629 - 637
  • [10] Identification and clinical validation of key genes as the potential biomarkers in colorectal adenoma
    Wang, Bangting
    Zhang, Jiting
    Wang, Xin
    Zhao, Lili
    Wang, Yan
    Fan, Zhining
    Liu, Li
    Gao, Wenqing
    BMC CANCER, 2023, 23 (01)